Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
UBS
Queensland Health
Baxter
Merck
Federal Trade Commission
AstraZeneca
McKesson

Generated: December 12, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SITAGLIPTIN PHOSPHATE

« Back to Dashboard

Clinical Trials for Sitagliptin Phosphate

Trial ID Title Status Sponsor Phase Summary
NCT00086515 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00418366 A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008) Completed Merck Sharp & Dohme Corp. Phase 1 A study to evaluate the effect of kidney disease, from mild to severe disease, on a diabetes medication
NCT00466518 Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant Unknown status University of Nebraska N/A This study is designed to look at the effect sitagliptin has on tacrolimus and sirolimus drug levels in kidney transplant patients. It is also designed to look at the side effects experienced in the transplant population.
NCT00847080 Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism Completed Merck Sharp & Dohme Corp. Phase 4 The purpose of this study is to determine whether sitagliptin is effective in the treatment of reactive hypoglycemia by dysinsulinism.
NCT00847080 Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Phase 4 The purpose of this study is to determine whether sitagliptin is effective in the treatment of reactive hypoglycemia by dysinsulinism.
NCT00888238 A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179) Completed Merck Sharp & Dohme Corp. Phase 1 This study will evaluate the effect of a single dose of sitagliptin on glucose dependent insulin secretion using a meal tolerance test (MTT) during a hyperglycemic clamp (HCG) procedure.
NCT01357148 A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235) Terminated Merck Sharp & Dohme Corp. N/A The primary objective of this study is to obtain safety information on the use of sitagliptin phosphate/metformin hydrochloride (HCl) (JANUMET®) from endocrinologists, diabetologists, internists, and general practitioners.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Sitagliptin Phosphate

Condition Name

Condition Name for Sitagliptin Phosphate
Intervention Trials
Type 2 Diabetes Mellitus 3
Type 2 Diabetes 2
Renal Insufficiency 1
Reactive Hypoglycemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Sitagliptin Phosphate
Intervention Trials
Diabetes Mellitus, Type 2 7
Diabetes Mellitus 6
Cardiovascular Diseases 1
Hypoglycemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Sitagliptin Phosphate

Trials by Country

Trials by Country for Sitagliptin Phosphate
Location Trials
United States 3
China 1
Mexico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Sitagliptin Phosphate
Location Trials
Colorado 1
New York 1
Nebraska 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Sitagliptin Phosphate

Clinical Trial Phase

Clinical Trial Phase for Sitagliptin Phosphate
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 1 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Sitagliptin Phosphate
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 1
Recruiting 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Sitagliptin Phosphate

Sponsor Name

Sponsor Name for Sitagliptin Phosphate
Sponsor Trials
Merck Sharp & Dohme Corp. 7
First Affiliated Hospital Xi'an Jiaotong University 1
University of Colorado, Denver 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Sitagliptin Phosphate
Sponsor Trials
Industry 7
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Merck
McKesson
Chinese Patent Office
Accenture
Healthtrust
Cantor Fitzgerald
UBS
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.